CanMove: A Physical Activity Program for Children With Cancer

Pediatric Cancer Clinical Trial

Official title: CanMove: The Feasibility of Implementing a Physical Activity Intervention for Children Undergoing Acute Cancer Treatment

Status Completed

Clinical Trial Summary

This study will evaluate a physical activity intervention for children during acute cancer treatment. The intervention aims to encourage children to participate in increased levels of physical activity and reduce the amount of time they spend engaged in sedentary activities. This study also aims to evaluate different ways of assessing physical function in order to determine the best outcome measure to use for children during acute cancer treatment.

Clinical Trial Description

All participants will receive the intervention which involves weekly sessions with a physiotherapist and the provision of an activity tracker. The sessions will aim to help motivate participants to be more physically active and identify barriers to physical activity in their environment. The activity tracker will be used to set a steps per day goal for the participant to achieve.

The intervention will be assessed for feasibility using aspects of the Bowen Framework. Under this framework the intervention will be evaluated according to different domains:

• Acceptability: To what extent is a new idea, program, process or measure judged as suitable or satisfying

• Demand: To what extent is a new idea, program, process, or measure likely to be used

• Implementation: To what extent can a new program is successfully delivered to intended participants

• Practicality: To what extent can the program can be carried out with intended participants using existing means, resources, and circumstances

• Limited efficiency: Does the a new program show promise of being successful with the intended population

In order to find out the best way to assess physical function, participants will complete 5 different assessments. The results from these assessments will help to determine the best measure to use in this population. ;

Related Conditions & MeSH terms

• Pediatric Cancer

• NCT number: NCT04483362
• Study type: Interventional
• Source: Murdoch Childrens Research Institute
• Status: Completed
• Phase: N/A
• Start date: November 9, 2020
• Completion date: September 3, 2021